The Safety Evaluation of the GSK-580299 Vaccine in Women from the Control Group in the Primary NCT00294047 Study

This extension learn about is designed to investigate the safety of GSK Biologicals HPV vaccine GSK580299 in feminine subjects who took phase in the primary find out about NCT00294047 and acquired the regulate vaccine in countries for which the licensed GSK HPV vaccine just isn’t indicated for the topics age team (26 years and older). This learn about is therefore conducted to allow all girls who got the regulate placebo in the main NCT00294047 study to receive the GSK580299 vaccine.